Abstract
Dry powder inhalers offer many advantages in the management, prevention and treatment of various respiratory diseases and also with tumors associated with lungs. The present study investigated the feasibility of formulating Cisplatin loaded Gelatin nanoparticles as colloidal drug carriers and converting them into dry powders by coating with inhalable lactose by freeze drying. The average particle size of Cisplatin gelatin nanoparticles was found to be 314 nm by two step desolvation technique. The mean geometric size of the carrier particles was found to be 2.8 ± 0.3 µm. Freeze dried nanoparticles were further mixed with various grades of inhalable lactoses and filled into hard gelatin capsules. In-vitro drug deposition pattern and physicochemical characteristics of nanoparticulate and conventional dry powder inhaler capsule formulation were compared. Results indicated that the developed gelatin nanoparticulate dry powder inhaler capsules possessed higher respirable fraction of 31.4% as compared to conventional dry powder capsule formulation.
The present investigation demonstrates that there is a possibility of delivering the nanoparticles to the lungs by incorporating them into carrier particles by simple adsorption. This provides an innovative path for delivering cytotoxic drugs to the lungs by inhalation.
Keywords: Cisplatin, desolvation, dry powder inhalers, lung cancer, nanoparticles.
Current Nanoscience
Title:Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer
Volume: 9 Issue: 4
Author(s): Amrita K. Rao, Shruti Shrikhande and Amrita Bajaj
Affiliation:
Keywords: Cisplatin, desolvation, dry powder inhalers, lung cancer, nanoparticles.
Abstract: Dry powder inhalers offer many advantages in the management, prevention and treatment of various respiratory diseases and also with tumors associated with lungs. The present study investigated the feasibility of formulating Cisplatin loaded Gelatin nanoparticles as colloidal drug carriers and converting them into dry powders by coating with inhalable lactose by freeze drying. The average particle size of Cisplatin gelatin nanoparticles was found to be 314 nm by two step desolvation technique. The mean geometric size of the carrier particles was found to be 2.8 ± 0.3 µm. Freeze dried nanoparticles were further mixed with various grades of inhalable lactoses and filled into hard gelatin capsules. In-vitro drug deposition pattern and physicochemical characteristics of nanoparticulate and conventional dry powder inhaler capsule formulation were compared. Results indicated that the developed gelatin nanoparticulate dry powder inhaler capsules possessed higher respirable fraction of 31.4% as compared to conventional dry powder capsule formulation.
The present investigation demonstrates that there is a possibility of delivering the nanoparticles to the lungs by incorporating them into carrier particles by simple adsorption. This provides an innovative path for delivering cytotoxic drugs to the lungs by inhalation.
Export Options
About this article
Cite this article as:
Rao K. Amrita, Shrikhande Shruti and Bajaj Amrita, Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer, Current Nanoscience 2013; 9 (4) . https://dx.doi.org/10.2174/1573413711309040005
DOI https://dx.doi.org/10.2174/1573413711309040005 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Treatments of Primary Sclerosing Cholangitis
Current Medicinal Chemistry Molecular and Biochemical Changes of the Cardiovascular System due to Smoking Exposure
Current Pharmaceutical Design Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Flavonoids Influence Epigenetic-Modifying Enzyme Activity: Structure-Function Relationships and the Therapeutic Potential for Cancer
Current Medicinal Chemistry Synthesis and In-Vitro Antitumor Activity of Selected 7-Fluoro-6-(4-methyl-1-piperazinyl)-2-(thiosubstituted)-4(3H)-quinazolinones
Letters in Organic Chemistry Antibody-Targeted Immunoliposomes for Cancer Treatment
Mini-Reviews in Medicinal Chemistry New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia
Current Cancer Drug Targets MDM4 (MDMX) and its Transcript Variants
Current Genomics Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma
Anti-Cancer Agents in Medicinal Chemistry 6,7-Dimethoxyquinazolines as Potential Cytotoxic Agents: Synthesis and in vitro Activity
Letters in Drug Design & Discovery Editorial (Hot Topic: Therapeutic Potential of Fetal Mesenchymal Stem Cells)
Current Stem Cell Research & Therapy State of the Art in African Trypanosome Drug Discovery
Current Topics in Medicinal Chemistry Antiproliferative Effects of Nerium oleander Leaves and Their Cardiac Glycosides Odoroside A and Oleandrin on MCF-7 Cancer Cells
Current Traditional Medicine The Complex Airway in Childhood Asthma
Current Pediatric Reviews The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.
Current Pharmaceutical Biotechnology Renal Solute Transporters and Their Relevance to Serum Urate Disorder
Current Hypertension Reviews Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
Endocrine, Metabolic & Immune Disorders - Drug Targets iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors
Current Pharmaceutical Design Targeting Regulatory T Cells for Anticancer Therapy
Mini-Reviews in Medicinal Chemistry